New omicron sublineages surge, but Pfizer-BioNTech bivalent booster retains effectiveness Post author: Post published:October 30, 2023 Post category:uncategorized The efficacy of the bivalent Pfizer-BioNTech COVID-19 messenger ribonucleic acid (mRNA) vaccine BNT162b2 BA.4/5. You Might Also Like New histone tag discovery offers hope for myelin repair in neurodegenerative diseases August 12, 2024 NYU Langone Health continues streak of “A” safety rating from Leapfrog November 17, 2024 FreeStyle Libre Troubleshooting: Aches and Errors January 16, 2024
New histone tag discovery offers hope for myelin repair in neurodegenerative diseases August 12, 2024